Enhancing project management with analytics creates project intelligence, shifting a task-based activity to a performance-driven one. This article discusses the importance of using actionable insights within pharmaceutical and biotech industries and the benefits that they provide.
Current market conditions, such as regulations and mergers or acquisitions, make improving compliance and manufacturing efficiency while driving to grow revenue and margins difficult. Life sciences companies must forge a new path that improves maturity, merges teams, processes, and technologies, and expands the participation and focus of quality to cross-functional and executive teams.
Electronic lab notebooks (ELNs) are one of the primary scientific informatics solutions for helping scientists design, execute, analyze and report on experiments — but selecting the right ELN can be a challenge. Rule number one: It pays to ask the right questions early in the assessment/selection process — during your initial prepurchase engagements with vendors.
With transformational changes in biologics, there are increasingly newer formats of new biologic drugs including bispecific antibodies, antibody drug conjugates and antibody-peptide fusion proteins. These formats are expanding the biologics world and new treatment modalities, however, these new formats have increased challenges for drug development.
The FDA expects organizations to have full visibility and control over their processes — with shared responsibility for contract manufacturing. However, over half of pharmaceutical manufacturing companies are not using software applications to manage or analyze any of their production processes.